Abiopharma

Events and transactions - supplemental report

Private offering of 3,100,000 shares to Clal Insurance Company – approximately 7.88% after allocation

Extension of the exclusivity period in a letter of intent for an investment in a server farm company in the USA until 7.8.26

Holdings of interested parties/officers as of 30.6.26

Ceased to be an interested party - Sigal Shahar

Management and officers – staffing as of 3.5.26 – periodic report correction

Trustee’s report for the BONDS (Series 1) for 2025 – Mishmeret

Understandings for the allocation of 20% of Rimon Power to Mizrahi Tefahot in return for 87.5 million NIS that will be injected into Rimon Power, details, continued

Register of shareholders, changes and share capital status – private placement – periodic report amendment

Register of shareholders, changes and capital status – private allocation